High blood pressure: Nine causes of the potentially deadly condition

HIGH blood pressure affects around a third of adults in the UK, but many people don ’t realise they have it. So what causes the condition? There are nine factors that could raise a person's risk of developing a high reading.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

High blood pressure? There ’s an app for that. Diabetes? There’s an app for that, too. Want to quit smoking? Keep track of your exercise? Is your anxiety getting the better of you? There are apps for all of those health issues, hundreds of thousands of apps. Developers at Blue Shield of California have rolled out a ne w, enhanced Wellvolution website — Wellvolution Next — that brings together roughly 40 of the best “digital therapeutics” applications in one place where members can…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Publication date: Available online 12 November 2019Source: Life SciencesAuthor(s): Eman Soliman, Shereen F. Behairy, Nabila N. El-maraghy, Shimaa M. ElshazlyAbstractPeroxisome proliferator-activated receptor γ (PPAR-γ) agonist, pioglitazone, is used clinically to improve the glycemic state in patients with type-2 diabetes mellitus. Independent of its blood glucose-lowering properties, pioglitazone ameliorates different cardiovascular disorders. The aim of the present study was to investigate the effect of pioglitazone on cardiovascular complications of N-nitro-L-arginine methyl ester (L-NAME)-induced hypertensi...
Source: Life Sciences - Category: Biology Source Type: research
Publication date: Available online 12 November 2019Source: The Journal of Steroid Biochemistry and Molecular BiologyAuthor(s): Luisa Paizoni, Matthias K. Auer, Heinrich Schmidt, Angela Hübner, Martin Bidlingmaier, Nicole ReischAbstractData on cardiovascular morbidity in adults with congenital adrenal hyperplasia (CAH) is sparse. We therefore aimed to determine the role of androgen control and glucocorticoid therapy on metabolic health. For that purpose, we included 90 patients (N = 39 men, N = 51 women) with classic CAH due to 21-hydroxylase deficiency (N = 61 salt wasting, N&...
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
ConclusionsIn patients with CKD referred for right heart catheterization, PH is common and associated with poor survival. Combined pre- and postcapillary PH was common and portended the worst survival for patients with CKD
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
We present the case of a 77-year-old woman with a history of a Whipple procedure for pancreatic adenocarcinoma who presented to the emergency department after the start of gemcitabine therapy with increased erythema, swelling, and tenderness in her lower legs. Relevant past medical history included peripheral vascular disease, dyslipidemia, and hypertension. A diagnosis of gemcitabine-induced pseudocellulitis aggravated by venous stasis was confirmed after an extensive workup. This case report and the literature review describe this rare reaction, highlighting the need for increased recognition to avoid unnecessary therape...
Source: Current Oncology - Category: Cancer & Oncology Tags: Curr Oncol Source Type: research
ConclusionAlthough Meckel’s diverticulitis is a rare entity, it can appear as an acute abdomen. An early diagnosis and treatment to prevent subsequent complications is essential to ensure an optimal recovery.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Condition:   Arterial Hypertension Intervention:   Sponsor:   Federal State Budgetary Scientific Institution, Research Institute of Cardiology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Hypertension, Dyslipidemia Interventions:   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug);   Drug: Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug);   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug) Sponsor:   Daewoong Pharmaceutical Co. LTD. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Dyslipidemias;   Diabetes Mellitus, Type 2;   Hypertension Intervention:   Dietary Supplement: Nutraceutical Sponsor:   University of Pavia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionThe changes in functional connectivity and structural connectivity within the DMN attributed to WMH progression were responsible for the development of cognitive impairment.
Source: NeuroImage: Clinical - Category: Radiology Source Type: research
More News: Health | Hypertension